Preclinical evaluation of the anti-inflammatory activity of moringa oil

Sarmiento Tomalá, Burbano Gómez, Soledispa Cañarte, López Barrera, Valdiviezo Rogel and Jimenez Granizo

Health Leadership and Quality of Life, 2024, vol. 3, .543

Abstract: The use of NSAIDs has a maximum ceiling effect, the dose increase does not improve the therapeutic activity, but it increases the adverse effects; Irrational, continuous, and prolonged use produces toxic reactions. The purpose of this research is to present a natural alternative (oil of Moringa oleifera); in which the anti-inflammatory activity property attributed to the fatty acids present in the chemical composition was evaluated. So we have: Omega 3 (89.21%), Omega 6 (11.90%) being these which participate in the process of anti-inflammation. Five groups of seven albino mice OF-01 each, were made. With the help of a micropipette the phlebogen agent (2% croto oil) was applied to the right ear, causing inflammation (edema). Then, the different treatments were placed: Group (A) negative control without treatment with inflammation, (B) positive control (diclofenac), groups (C, D, E) treated with the oil in volume (ul): 20 , 40, 60 respectively. After four hours euthanasia was given to animals, the ears were cut and a 6 mm diameter disc was obtained from each one (right and left ear), finally these were weighed. At the end of the study the following average weights of the ears were obtained (right): (A) 12.49 ± 2.73; (B) 9.56 ± 3.19; (C) 9.41 ± 1.52; (D) 8.61 ± 1.27; (E) 8.86 ± 1.73. Average percentages of inflammation: (A) 96.65 ± 5.10; (B) 61.33 ± 17.30; (C) 60.69 ± 8.64; (D) 28.64 ± 13.38; (E) 34.15 ± 11.37.The percentage of inhibition (A) 0, (B) (36.54%), (C) (37.21%), (D) (70.36%), (E) (64.66%). There was a significant difference p

Date: 2024
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:dbk:health:v:3:y:2024:i::p:.543:id:.543

DOI: 10.56294/hl2024.543

Access Statistics for this article

More articles in Health Leadership and Quality of Life from AG Editor
Bibliographic data for series maintained by Javier Gonzalez-Argote ().